A Prospective Multicenter Longitudinal Cohort Study of the Mymobility Platform
Completed · Not applicable · NCT03737149
Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip
At a glance
- Research payments reported, 2025
- $708
- U.S. investigators named
- 2
- Sites paid
- 1
- Planned or actual enrollment
- 6,559
About the trial
- Sponsor
- Zimmer Biomet
- Tested
- mymobility with Apple Watch (other)
- Dates
- Started 2018-10-22; completion 2025-04-15
- Results posted
- Yes
Post-market prospective, multi-center longitudinal study to determine if mobile application-guided education and exercise paired with accurate and sensitive activity monitoring, captured from consumer wearables, can provide a viable (and potentially improved) alternative to current standard of care physical therapy for hip and knee arthroplasty.
From ClinicalTrials.gov, last updated 2026-03-23. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Zimmer Biomet Holdings, Inc. reported $708 in research payments for this study in 2025 (2 payments).
Products named: Mymobility Platform
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Jared R. Foran, MD Orthopedic Surgery · Golden, CO
- Krishna R. Tripuraneni, MD Joint Replacement Surgery · Albuquerque, NM
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Wcg Irb $708
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.